American Healthcare REIT Highlights Q3 Results and New Guidance
American Healthcare REIT, Inc. ("the Company" or "AHR") has shared its results for the third quarter of 2024 and has enhanced its financial forecast for the year. Recent acquisitions significantly contribute to this revised guidance, as AHR positions itself for an improving market landscape.
Notable Financial Metrics
Recent Earnings Performance
For the quarter ending September 30, 2024, AHR reported a GAAP net loss of $(3.1) million, translating to a net loss of $(0.03) per diluted share. In contrast, the normalized funds from operations (NFFO) were notably better, reaching $0.36 per diluted share. Most importantly, the Company's Same-Store Net Operating Income (NOI) experienced an impressive growth of 17.0% over the same period in 2023.
Acquisition Strategy and its Impact
Portfolio Growth and Performance Expectations
AHR initiated a strategic acquisition, obtaining a senior housing portfolio valued at approximately $36.2 million in assumed debt. This portfolio will enhance the Company's offerings and was acquired with manageable debt costs. Additionally, AHR became the sole owner of Trilogy by acquiring a 24% minority membership interest for about $258 million. This acquisition aligns with the Company's focus on expanding its Integrated Senior Health Campuses (ISHC), which has shown substantial growth in different segments.
Increased Guidance for 2024
The enhanced portfolio performance has led AHR to revise its 2024 guidance upward. NFFO guidance is now expected to range between $1.40 and $1.43 per share, up from previous estimates of $1.23 to $1.27. The overall Same-Store NOI growth guidance has also been refined to a range of 15.0% to 17.0% compared to the earlier prospect of 12.0% to 14.0%. This positive revision illustrates management's confidence in AHR's prospects as they navigate the current market conditions.
Operational Efficiency and Market Position
AHR has made substantial efforts to improve operational efficiencies, which has resulted in a positive change in their Net-Debt-to-Annualized Adjusted EBITDA ratio, which has improved from 5.9x to 5.1x. The low debt relative to earnings emphasizes the strength of AHR’s balance sheet, which positions them well for future investments and expansions.
Leadership Perspectives
Following these results, Danny Prosky, President and CEO, reflected on the Company's strategic moves, stating, "We are excited about completing our follow-on offering and acquiring the remaining ownership interest in Trilogy Holdings. Our focus will remain on providing quality healthcare within our communities and expanding our market share in the senior housing sector."
Financial Performance Overview
In 2024, AHR will continue to prioritize growth in its operating segments, particularly where achievable returns are favorable compared to overall market risks. This approach will enable consistent revenue generation while expanding their footprint across various healthcare property types, ensuring long-term value for shareholders.
Frequently Asked Questions
What were the key financial results for AHR in Q3 2024?
AHR reported a GAAP net loss of $(3.1) million, with NFFO at $0.36 per share, indicating strong operational performance despite the net loss.
How has AHR adjusted its 2024 financial guidance?
The revised NFFO guidance is between $1.40 to $1.43 per share, and Same-Store NOI growth guidance is now set to 15.0% to 17.0%.
What acquisitions were highlighted in the recent reports?
AHR acquired a senior housing portfolio valued at around $36.2 million and purchased the remaining 24% interest in Trilogy Holdings for approximately $258 million.
What improvements have been made in AHR's debt metrics?
AHR achieved a Net-Debt-to-Annualized Adjusted EBITDA improvement to 5.1x, reflecting successful debt management strategies.
What is the focus of AHR's future growth strategy?
AHR aims to expand its Integrated Senior Health Campuses while leveraging its existing partnerships and operators to drive returns within the healthcare real estate sector.
